9O6 Stock Overview
Molekule Group, Inc., an interior space air purification technology company, provides air purification solutions for hospitals and other healthcare facilities.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Molekule Group, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.082 |
52 Week High | US$2.42 |
52 Week Low | US$0.082 |
Beta | -3.86 |
11 Month Change | 0% |
3 Month Change | -40.62% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -99.60% |
Recent News & Updates
Recent updates
Shareholder Returns
9O6 | DE Building | DE Market | |
---|---|---|---|
7D | 0% | -1.6% | -2.2% |
1Y | n/a | -13.0% | 13.3% |
Return vs Industry: Insufficient data to determine how 9O6 performed against the German Building industry.
Return vs Market: Insufficient data to determine how 9O6 performed against the German Market.
Price Volatility
9O6 volatility | |
---|---|
9O6 Average Weekly Movement | n/a |
Building Industry Average Movement | 4.8% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9O6's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 9O6's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 92 | Jason DiBona | molekule.com |
Molekule Group, Inc., an interior space air purification technology company, provides air purification solutions for hospitals and other healthcare facilities. The company offers interior air sterilization and disinfection products for the eradication of harmful airborne pathogens, including COVID-19. Its air hygiene product, Purgo (pure-go), a medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology applied in any indoor space, including in hospitals, offices, and elevators.
Molekule Group, Inc. Fundamentals Summary
9O6 fundamental statistics | |
---|---|
Market cap | €315.23k |
Earnings (TTM) | -€30.46m |
Revenue (TTM) | €19.87m |
0.0x
P/S Ratio0.0x
P/E RatioIs 9O6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9O6 income statement (TTM) | |
---|---|
Revenue | US$21.74m |
Cost of Revenue | US$13.51m |
Gross Profit | US$8.23m |
Other Expenses | US$41.55m |
Earnings | -US$33.32m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.87 |
Gross Margin | 37.86% |
Net Profit Margin | -153.26% |
Debt/Equity Ratio | 88.9% |
How did 9O6 perform over the long term?
See historical performance and comparison